Viewing Study NCT00002451


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-01-05 @ 9:57 PM
Study NCT ID: NCT00002451
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2000-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module